z-logo
open-access-imgOpen Access
National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey
Author(s) -
Ali McBride,
Sarah Hudson-Disalle,
Jeffrey Pilz,
Mark Hamm,
Brooke Boring,
Larry W. Buie,
David L. DeRemer
Publication year - 2022
Publication title -
jco oncology practice
Language(s) - English
Resource type - Journals
eISSN - 2688-1535
pISSN - 2688-1527
DOI - 10.1200/op.21.00883
Subject(s) - medicine , pharmacy , economic shortage , oncology , hematology , adverse effect , clinical oncology , family medicine , intensive care medicine , cancer , linguistics , philosophy , government (linguistics)
Drug shortages are a clear and growing challenge. Prominent shortages included oncology medications and supportive care products essential for the care of patients with cancer. Oncology drug shortages often result in disruptions in the timing of chemotherapy treatments, alterations in the dose or regimen administered, or even missed doses when alternative agents are unavailable. The purpose of this survey was to characterize the impact of oncology drug shortages across the United States, including the experiences of health care organizations, resource implications, and the impact on patient safety, patient care, and clinical trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom